Published in Surgery on May 01, 1992
Thromboangiitis Obliterans (Buerger's Disease)-Current Practices. Int J Inflam (2013) 1.12
Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors. Int J Stem Cells (2011) 0.93
Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices. Int J Angiol (2009) 0.90
Thromoboagiitis Obliterans (TAO). Int J Stem Cells (2010) 0.89
Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients. Clin Exp Immunol (2012) 0.77
Possible involvement of Notch signaling in the pathogenesis of Buerger's disease. Surg Today (2013) 0.76
Thromboangiitis Obliterans (Buerger's Disease). Eplasty (2015) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict (1989) 6.58
Programmable and autonomous computing machine made of biomolecules. Nature (2001) 3.51
Demonstration of contractile protein in endothelium and cells of the heart valves, endocardium, intima, arteriosclerotic plaques, and Aschoff bodies of rheumatic heart disease. Am J Pathol (1969) 2.86
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial. Neurology (2012) 2.54
Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem (1969) 2.49
Demonstration of actomyosin in mesangial cells of the renal glomerulus. Am J Pathol (1972) 2.39
Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36
Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Proc Natl Acad Sci U S A (1966) 2.25
Antigen-specific thymus cell factors in the genetic control of the immune response to poly-(tyrosyl, glutamyl)-poly-D, L-alanyl--poly-lysyl. J Exp Med (1974) 2.19
Antigen-specific T-cell factors in the genetic control of the immune response to poly(Tyr,Glu)-polyDLAla--polyLys. Evidence for T- and B-cell defects in SJL mice. J Exp Med (1975) 1.98
Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg (1977) 1.97
Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis. AJR Am J Roentgenol (2003) 1.92
Fatal complications of central venous catheters. Br Med J (1971) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Axonal regrowth after spinal cord transection in adult zebrafish. J Comp Neurol (1997) 1.91
Acute acalculous cholecystitis. An increasing entity. Ann Surg (1982) 1.83
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med (1983) 1.79
The nature of the antigenic determinant in a genetic control of the antibody response. J Exp Med (1969) 1.74
Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med (1991) 1.64
Determination of gestational cocaine exposure by hair analysis. JAMA (1989) 1.63
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest (1999) 1.62
Long-term endemism of two highly divergent lineages of the amphibian-killing fungus in the Atlantic Forest of Brazil. Mol Ecol (2014) 1.61
Enhancing effect of type specific antistreptococcal antibodies on emergence of streptococci rich in M-protein. Proc Soc Exp Biol Med (1967) 1.58
The genetic control of antibody specificity. J Exp Med (1969) 1.58
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. J Rheumatol (1994) 1.56
Thymus-independence of slowly metabolized immunogens. Proc Natl Acad Sci U S A (1972) 1.52
Treatment of idiopathic club foot using the Ponseti method. Initial experience. J Bone Joint Surg Br (2006) 1.52
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood (1996) 1.51
Thromboangiitis obliterans: an old disease in need of a new look. Int J Cardiol (2000) 1.49
Early reoperation for perirectal abscess: a preventable complication. Dis Colon Rectum (2001) 1.49
Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother (1989) 1.45
The experimental induction of glomerulonephritis like that in man by infection with group A streptococci. J Exp Med (1968) 1.40
No HLA antigen is significant in classic Kaposi's sarcoma. J Am Acad Dermatol (1993) 1.39
The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol (2000) 1.38
In vitro and in vivo induction of effector T cells mediating DTH responses to a protein and a synthetic polypeptide antigen. Cell Immunol (1979) 1.38
Activation of factor XII by tobacco glycoprotein. J Exp Med (1977) 1.34
Genetic control of immune responses. Curr Top Microbiol Immunol (1972) 1.34
The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum (1989) 1.28
Synthesis of basement membrane collagen by cultured human endothelial cells. J Exp Med (1976) 1.27
Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis (2005) 1.24
The role of thymus cells in the immune response to poly(Tyr, Glu)-polyD L Ala--polyLys as a function of the genetic constitution of the mouse strain. Eur J Immunol (1974) 1.24
Type I procollagen C-proteinase from mouse fibroblasts. Purification and demonstration of a 55-kDa enhancer glycoprotein. Eur J Biochem (1989) 1.21
T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor. Nature (1980) 1.19
Hypersensitivity to tobacco antigen. Proc Natl Acad Sci U S A (1976) 1.16
Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin. J Exp Med (1974) 1.15
The T4 surface antigen is involved in the induction of helper function. J Immunol (1984) 1.14
FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation. FEBS Lett (2002) 1.14
Distribution and symmetry of arteriosclerotic lesions of the lower extremities: an arteriographic study of 200 limbs. Cardiovasc Intervent Radiol (1985) 1.12
Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process. J Exp Med (1980) 1.11
Resolution of mouse and human immunoglobulin G into two fractions by chromatography on diethylaminoethyl-sephadex. Relation of mouse antibody type to the antigen charge. Isr J Med Sci (1969) 1.10
Immune response of mice to nucleic acids: strain-dependent differences in magnitude and class of antibody production. J Immunol (1973) 1.10
The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Eur J Immunol (1989) 1.10
Cellular localization of tyrosine hydroxylase by immunohistochemistry. J Histochem Cytochem (1975) 1.09
Induction of acute cholecystitis by activation of factor XII. J Exp Med (1980) 1.08
Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation (1999) 1.08
Analysis of the biological functions and fine specificity of (T,G)-A--L specific T cell clones. Immunobiology (1986) 1.08
Bilateral necrotising scleritis with marginal corneal ulceration after cataract surgery in a patient with vasculitis. Br J Ophthalmol (1980) 1.08
Occurrence of caterpillar nuclei within normal immature and normal appearing and altered mature heart muscle cells and the evolution of Anitschkow cells from the latter. Am J Pathol (1966) 1.08
Hydromediastinum. JAMA (1970) 1.07
Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. FASEB J (1990) 1.06
Vascular lesions associated with impotence in diabetic and nondiabetic arterial occlusive disease. Diabetes (1978) 1.06
The effect of genetic control of immune response to synthetic polypeptides on the response to homologous DNP-polypeptide conjugates. Immunochemistry (1969) 1.05
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit. Immunology (1990) 1.05
[Strain-dependent differences in the specificity of antibody responses toward lysozyme]. J Immunol (1971) 1.04
Role of antigenic structure in cell to cell cooperation. Proc Natl Acad Sci U S A (1976) 1.04
The nature of murine immune response to nucleic acids. J Immunol (1975) 1.03
Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol (2000) 1.03
Linkage between immune response potential to DNA and X chromosome. Nature (1974) 1.03
Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol (2000) 1.02
On the virulence of group A streptococci: evidence for virulence factors other than M-protein and capsule. Am J Pathol (1973) 1.02
alpha2-Macroglobulin on human vascular endothelium. J Exp Med (1976) 1.02
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol (2002) 1.02
Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol (1997) 1.01
Antigen-specific T cell factors: a fine analysis of specificity. J Immunol (1977) 1.01
Complications of saphenous vein harvesting following coronary artery bypass surgery. J Cardiovasc Surg (Torino) (1990) 1.01
In vitro correction of antigen-induced immune suppression: effects of histamine, dibutyryl cyclic AMP and cholera enterotoxin. Cell Immunol (1974) 1.01
Esophageal ulceration and oral potassium chloride ingestion. Chest (1974) 1.01
Antigen specific T-cell helper factor cross reacts idiotypically with antibodies of the same specificity. Nature (1979) 1.01
Angiographic diagnosis and differential diagnosis of islet-cell tumors. Am J Roentgenol Radium Ther Nucl Med (1973) 1.01
Regenerating descending axons preferentially reroute to the gray matter in the presence of a general macrophage/microglial reaction caudal to a spinal transection in adult zebrafish. J Comp Neurol (2001) 1.01
How does infected bile affect the postoperative course of patients undergoing laparoscopic cholecystectomy? Am J Surg (1996) 1.00
The genetic regulation of the induction of experimental SLE. Immunology (1990) 1.00
Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Proc Natl Acad Sci U S A (1997) 1.00
Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest (1995) 1.00
(T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus. Clin Exp Immunol (1985) 0.99
Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol (1988) 0.99
Cross-reactive idiotypic determinants on murine anti-(T,G)-A--L antibodies. J Immunol (1978) 0.99
A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. Proc Natl Acad Sci U S A (1997) 0.99